Odonate Therapeutics Inc (ODT) Stock Price, Quote, News and Overview
NASDAQ:ODT - Nasdaq - Common Stock
ODT Quote, Performance and Key Statistics
1.12
-0.05 (-4.27%)
The current stock price of ODT is 1.12 null. In the past month the price decreased by -21.13%. In the past year, price decreased by -94.4%.
ODT Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 67.21 | 829.40B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 27.44 | 390.99B | ||
| JNJ | JOHNSON & JOHNSON | 16.25 | 390.76B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 20.56 | 230.17B | ||
| MRK | MERCK & CO. INC. | 11.71 | 226.40B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.77 | 215.98B | ||
| PFE | PFIZER INC | 8.46 | 149.04B | ||
| SNY | SANOFI-ADR | 13.58 | 136.54B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 48.97 | 113.23B | ||
| GSK | GSK PLC-SPON ADR | 7.78 | 74.77B | ||
| ZTS | ZOETIS INC | 27.1 | 72.39B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 31.95 | 44.58B |
Related stock screener links
About ODT
Company Profile
Odonate Therapeutics, Inc. is a pharmaceutical company, which engages in the development of therapeutics that improves and extends the lives of patients with cancer. The company is headquartered in New York City, New York and currently employs 137 full-time employees. The company went IPO on 2017-12-07. The firm is engaged in the development of therapeutics to improve and extend the lives of patients with cancer. The company is focused on the development of tesetaxel, a novel chemotherapy agent.
Company Info
Odonate Therapeutics Inc
3 East 28Th Street, 10Th Floor
New York City NEW YORK 10016 US
CEO: Kevin Tang
Employees: 137
Company Website: https://www.odonate.com/
Phone: 13322060935.0
Odonate Therapeutics Inc / ODT FAQ
What is the stock price of Odonate Therapeutics Inc today?
The current stock price of ODT is 1.12 null. The price decreased by -4.27% in the last trading session.
What is the ticker symbol for Odonate Therapeutics Inc stock?
The exchange symbol of Odonate Therapeutics Inc is ODT and it is listed on the Nasdaq exchange.
On which exchange is ODT stock listed?
ODT stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for Odonate Therapeutics Inc stock?
9 analysts have analysed ODT and the average price target is 4.08 null. This implies a price increase of 264.29% is expected in the next year compared to the current price of 1.12. Check the Odonate Therapeutics Inc stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is Odonate Therapeutics Inc worth?
Odonate Therapeutics Inc (ODT) has a market capitalization of 43.11M null. This makes ODT a Nano Cap stock.
How many employees does Odonate Therapeutics Inc have?
Odonate Therapeutics Inc (ODT) currently has 137 employees.
What are the support and resistance levels for Odonate Therapeutics Inc (ODT) stock?
Odonate Therapeutics Inc (ODT) has a resistance level at 1.25. Check the full technical report for a detailed analysis of ODT support and resistance levels.
Should I buy Odonate Therapeutics Inc (ODT) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ODT, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ODT, evaluating the profitability, health, valuation and growth aspects
- Odonate Therapeutics Inc (ODT) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- Odonate Therapeutics Inc (ODT) Sales and EPS estimates to see what analysts future expectations are.
- Odonate Therapeutics Inc (ODT) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- Odonate Therapeutics Inc (ODT) Insider and Institutional Ownership to learn about the owners and their transactions.
- Odonate Therapeutics Inc (ODT) Stock Chart to make your own analysis
- Odonate Therapeutics Inc (ODT) Latest news and press-releases to stay up to date.
Does Odonate Therapeutics Inc (ODT) stock pay dividends?
ODT does not pay a dividend.
When does Odonate Therapeutics Inc (ODT) report earnings?
Odonate Therapeutics Inc (ODT) will report earnings on 2022-03-01, before the market open.
What is the Price/Earnings (PE) ratio of Odonate Therapeutics Inc (ODT)?
Odonate Therapeutics Inc (ODT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.68).
ODT Technical Analysis
ODT Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ODT. Both the profitability and financial health of ODT have multiple concerns.
ODT Financial Highlights
Over the last trailing twelve months ODT reported a non-GAAP Earnings per Share(EPS) of -2.68. The EPS increased by 31.46% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -96.5% | ||
| ROE | N/A | ||
| Debt/Equity | 0 |
ODT Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 47% to ODT. The Buy consensus is the average rating of analysts ratings from 9 analysts.